Skip to content
Disclosery

Weaver C. Barksdale & Associates, Inc.: ABBV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Weaver C. Barksdale & Associates, Inc. on ABBV, newest first. How the timeline and the estimate are built.

Weaver C. Barksdale & Associates, Inc. held 9,898 ABBV shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 9,898 shares
    Change vs previous 13F -11 shares

    2.23% of the 13F portfolio, value $2,490,799.

    13F-HR 0001214659-26-010105 filed by Weaver C. Barksdale & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 9,909 shares
    Change vs previous 13F +610 shares

    2.05% of the 13F portfolio, value $2,154,676.

    13F-HR 0001214659-26-006136 filed by Weaver C. Barksdale & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 9,299 shares
    Change vs previous 13F -1,132 shares

    2.23% of the 13F portfolio, value $2,124,319.

    13F-HR 0001214659-26-001653 filed by Weaver C. Barksdale & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 10,431 shares
    Change vs previous 13F -648 shares

    2.32% of the 13F portfolio, value $2,414,066.

    13F-HR 0001214659-25-016245 filed by Weaver C. Barksdale & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 11,079 shares
    Change vs previous 13F -101 shares

    1.97% of the 13F portfolio, value $2,056,733.

    13F-HR 0001214659-25-011831 filed by Weaver C. Barksdale & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 11,180 shares
    Change vs previous 13F -256 shares

    2.25% of the 13F portfolio, value $2,341,121.

    13F-HR 0001214659-25-007513 filed by Weaver C. Barksdale & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 11,436 shares
    Change vs previous 13F -276 shares

    1.95% of the 13F portfolio, value $2,032,709.

    13F-HR 0001214659-25-002428 filed by Weaver C. Barksdale & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 11,712 shares
    Change vs previous 13F not available

    2.08% of the 13F portfolio, value $2,312,940.

    13F-HR 0001214659-24-018832 filed by Weaver C. Barksdale & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).